Besides, study on activity of metformin against breast cancer cell lines showed that metformin significantly reduced both tyrosine and serine phosphorylation of STAT-3 (P-STAT-3 at Tyr705 or Ser727), reduced P-mTOR and induced P-AMPK/AMPK (Fig. 6D). Here, STAT3 is linked to breast cancer.